Hepatitis C DNA vaccine (ChronTech)

丙型肝炎DNA疫苗

Report date: 2022/07/19 16:22:54

Base Information

Drug NameHepatitis C DNA vaccine (ChronTech)
Drug Alias NameNS3/4a DNA vaccineChronVac-C
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulantsHepatitis C virus serine protease, NS3/NS4A modulators
TargetsHepatitis C virus serine protease, NS3/NS4A
Therapy Area/IndicationsHepatitis C, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesChrontech Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTripep AbChrontech Pharma Ab
Active IndicationsN/A
Inactive IndicationsHepatitis C, Chronic

Other Information

ATC CodeN/A
Related LinksN/A